Filing Flows › Accendra Health (ACH) › Q2 2026
Accendra Health (ACH) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 10, 2026
Accendra Health (ACH) reported revenue of $613M for the second quarter 2026 (Q2 2026), -10% from a year earlier and -2% from the quarter before. Operating margin was -5.7%, net loss $89.1M (14.5% of revenue).
Accendra Health, Q2 2026: revenue $613M (-10% year over year), operating margin -5.7%, net loss $89.1M, operating cash flow −$26.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $613M | -2% | -10% |
| Operating profit | −$35.1M | -305% | — |
| Net earnings | −$89.1M | — | — |
| Operating cash flow | −$26.0M | — | -169% |
What changed
Revenue was $613.2M in Q2 2026, down 10% year over year and down 2% from the previous quarter. Diabetes was the largest line at 32% of revenue. Sleep therapy lost $33.0M year over year (down 18%), 48% of the total change.
Operating costs exceeded revenue by $35.1M, an operating margin of -5.7%. Total costs fell 10% while revenue fell 10%. The quarter ended with a net loss of $89.1M, wider than the previous quarter's $6.5M loss. Net interest and other expense of $52.5M was the main reason.
Operating cash flow was −$26.0M. Non-cash charges added back $65.7M of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items used $6.6M. Capital expenditures of $47.6M exceeded it, leaving free cash flow of −$73.6M.
Questions
What was Accendra Health's revenue in the second quarter 2026?
Accendra Health (ACH) reported revenue of $613M for the second quarter 2026 (Q2 2026), -10% from a year earlier and -2% from the quarter before.
Was Accendra Health profitable in the second quarter 2026?
Operating loss was $35.1M (-5.7% of revenue) and net loss $89.1M.
Source: Accendra Health 10-Q on SEC EDGAR.